Skip to main content

Peer Review reports

From: Molecular subtyping based on immune cell marker genes predicts prognosis and therapeutic response in patients with lung adenocarcinoma

Original Submission
6 Feb 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
10 Mar 2023 Reviewed Reviewer Report
12 Jun 2023 Reviewed Reviewer Report
6 Jul 2023 Author responded Author comments - Ting-Dong Yu
Resubmission - Version 3
6 Jul 2023 Submitted Manuscript version 3
20 Jul 2023 Author responded Author comments - Ting-Dong Yu
Resubmission - Version 4
20 Jul 2023 Submitted Manuscript version 4
24 Aug 2023 Reviewed Reviewer Report
16 Sep 2023 Author responded Author comments - Ting-Dong Yu
Resubmission - Version 5
16 Sep 2023 Submitted Manuscript version 5
15 Oct 2023 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
27 Oct 2023 Editorially accepted
24 Nov 2023 Article published 10.1186/s12885-023-11579-7

You can find further information about peer review here.

Back to article page